Clinical research on the therapeutic effect of recombined human endostatin with interventional therapy for hepatic metastatic tumor from gastrointestinal tract
Phase of Trial: Phase IV
Latest Information Update: 21 May 2012
At a glance
- Drugs Endostatin (Primary)
- Indications Gastrointestinal cancer; Liver metastases
- Focus Therapeutic Use
- 21 May 2012 Planned end date changed to 31 Dec 2013 as reported by Chinese Clinical Trial Register.
- 21 May 2012 Actual initiation date 1 Jul 2010 added as reported by Chinese Clinical Trial Register.
- 21 Apr 2012 New trial record